메뉴 건너뛰기




Volumn 42, Issue 1, 2016, Pages 50-53

Assessing risk/benefit for trials using preclinical evidence: A proposal

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; HUMAN; MORALITY; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; STUDY DESIGN; ANIMAL EXPERIMENT; CLINICAL TRIAL (TOPIC); ETHICS; METHODOLOGY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RESEARCH ETHICS; RISK ASSESSMENT; STANDARDS; TREATMENT OUTCOME;

EID: 84953254457     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2015-102882     Document Type: Article
Times cited : (29)

References (20)
  • 1
    • 0000601871 scopus 로고    scopus 로고
    • Declaration of Helsinki
    • World Medical Association. Declaration of Helsinki. JAMA 2013;310:2191-4.
    • (2013) JAMA , vol.310 , pp. 2191-4
  • 3
    • 84861998609 scopus 로고    scopus 로고
    • Should preclinical studies be registered?
    • Kimmelman J, Anderson JA. Should preclinical studies be registered? Nat Biotechnol 2012;30:488-9.
    • (2012) Nat Biotechnol , vol.30 , pp. 488-9
    • Kimmelman, J.1    Anderson, J.A.2
  • 4
    • 0006266243 scopus 로고
    • Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-derived Products
    • In: Services USDoH, ed.
    • Guidance for Industry: Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-derived Products. In: Services USDoH, ed., 1995.
    • (1995)
  • 5
    • 84898407393 scopus 로고    scopus 로고
    • Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products
    • In: Services USDoHH, ed.
    • Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products. In: Services USDoHH, ed., 2013.
    • (2013)
  • 6
    • 84905438349 scopus 로고    scopus 로고
    • Guidance for Industry: Product Development Under the Animal Rule
    • U.S. Department of Health and Human Services FaDA, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for Industry: Product Development Under the Animal Rule 2014.
    • (2014)
  • 7
    • 0027524863 scopus 로고
    • Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents
    • Ratain MJ, Mick R, Schilsky RL, et al. Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents. J Natl Cancer Inst 1993;85:1637-43.
    • (1993) J Natl Cancer Inst , vol.85 , pp. 1637-43
    • Ratain, M.J.1    Mick, R.2    Schilsky, R.L.3
  • 8
    • 84881240391 scopus 로고    scopus 로고
    • Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments
    • Henderson VC, Kimmelman J, Fergusson D, et al. Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med 2013;10:e1001489.
    • (2013) PLoS Med , vol.10
    • Henderson, V.C.1    Kimmelman, J.2    Fergusson, D.3
  • 9
    • 84878898016 scopus 로고    scopus 로고
    • The laboratory rat: relating its age with human's
    • Sengupta P. The laboratory rat: relating its age with human's. Int J Prev Med 2013;4:624-30.
    • (2013) Int J Prev Med , vol.4 , pp. 624-30
    • Sengupta, P.1
  • 10
    • 79953704023 scopus 로고    scopus 로고
    • Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty
    • Kimmelman J, London AJ. Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PLoS Med 2011;8:e1001010.
    • (2011) PLoS Med , vol.8
    • Kimmelman, J.1    London, A.J.2
  • 11
    • 84872166025 scopus 로고    scopus 로고
    • Building an ethical foundation for first-in-human nanotrials
    • Dresser R. Building an ethical foundation for first-in-human nanotrials. J Law Med Ethics 2012;40:802-8.
    • (2012) J Law Med Ethics , vol.40 , pp. 802-8
    • Dresser, R.1
  • 13
  • 14
    • 77952844165 scopus 로고    scopus 로고
    • Extending clinical equipoise to phase 1 trials involving patients: unresolved problems
    • Anderson JA, Kimmelman J. Extending clinical equipoise to phase 1 trials involving patients: unresolved problems. Kennedy Inst Ethics J 2010;20:75-98.
    • (2010) Kennedy Inst Ethics J , vol.20 , pp. 75-98
    • Anderson, J.A.1    Kimmelman, J.2
  • 16
    • 84953257168 scopus 로고    scopus 로고
    • For Authors Manuscript Formatting Guide. Secondary For Authors Manuscript Formatting Guide
    • For Authors Manuscript Formatting Guide. Secondary For Authors Manuscript Formatting Guide. http://www.nature.com/nature/authors/gta/-a5.9
  • 17
    • 0742266629 scopus 로고    scopus 로고
    • "Special scrutiny": a targeted form of research protocol review
    • Levine C, Faden R, Grady C, et al. "Special scrutiny": a targeted form of research protocol review. Ann Intern Med 2004;140:220-3.
    • (2004) Ann Intern Med , vol.140 , pp. 220-3
    • Levine, C.1    Faden, R.2    Grady, C.3
  • 18
    • 77950572352 scopus 로고    scopus 로고
    • Publication bias in reports of animal stroke studies leads to major overstatement of efficacy
    • Sena ES, van der Worp HB, Bath PM, et al. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 2010;8:e1000344.
    • (2010) PLoS Biol , vol.8
    • Sena, E.S.1    van der Worp, H.B.2    Bath, P.M.3
  • 19
    • 41249090758 scopus 로고    scopus 로고
    • Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach
    • Crossley NA, Sena E, Goehler J, et al. Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach. Stroke 2008;39:929-34.
    • (2008) Stroke , vol.39 , pp. 929-34
    • Crossley, N.A.1    Sena, E.2    Goehler, J.3
  • 20
    • 84860445985 scopus 로고    scopus 로고
    • Research ethics. Rethinking research ethics: the case of postmarketing trials
    • London AJ, Kimmelman J, Carlisle B. Research ethics. Rethinking research ethics: the case of postmarketing trials. Science 2012;336:544-5.
    • (2012) Science , vol.336 , pp. 544-5
    • London, A.J.1    Kimmelman, J.2    Carlisle, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.